Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
18 September 2006 - 11:05PM
PR Newswire (US)
CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will webcast
corporate presentations at Merrill Lynch's Global Pharmaceutical,
Biotech and Medtech Conference on September 21, 2006 and at the UBS
Global Life Sciences Conference on September 26, 2006. Ian Smith,
Executive Vice President and Chief Financial Officer of Vertex,
will present at the Merrill Lynch Conference. The presentation and
discussion will be conducted on Thursday, September 21, 2006 at
10:40 a.m. BST (5:40 a.m. EDT). Joshua Boger, Ph.D., President and
Chief Executive Officer of Vertex, will present at the UBS Global
Life Sciences Conference on Tuesday, September 26, 2006 at 1:00
p.m. EDT. The presentations will be webcast live and may be
accessed by visiting the Vertex website at http://www.vrtx.com/. A
replay of the webcasts will also be available on the Company's
website for two weeks following the presentations. To access the
webcasts, go to Vertex's website and select the desired
presentation from the 'Events Calendar.' To ensure a timely
connection, it is recommended that users register at least 15
minutes prior to the scheduled webcast. About Vertex Vertex
Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small
molecule drugs for serious diseases. The Company's strategy is to
commercialize its products both independently and in collaboration
with major pharmaceutical companies. Vertex's product pipeline is
focused on viral diseases, inflammation, autoimmune diseases,
cancer, pain and bacterial infection. Vertex co-discovered the HIV
protease inhibitor, Lexiva, with GlaxoSmithKline. Lexiva is a
registered trademark of the GlaxoSmithKline group of companies.
Vertex's press releases are available at http://www.vrtx.com/.
Vertex Contact: Lora Pike, Manager, Investor Relations, (617)
444-6755 DATASOURCE: Vertex Pharmaceuticals Incorporated CONTACT:
Lora Pike, Manager, Investor Relations of Vertex Pharmaceuticals
Incorporated, +1-617-444-6755 Web site: http://www.vrtx.com/
Company News On-Call: http://www.prnewswire.com/comp/938395.html
Copyright